🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,756 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10005833

Methods of treating inflammation associated airway diseases and viral infections

The Board of Regents of the University of Texas System · Granted Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10004687

Liposomal curcumin for treatment of diseases

The Board of Regents of the University of Texas System · Granted Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9993537

Methods and compositions related to Th-1 dendritic cells

The Board of Regents of the University of Texas System · Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9987363

Materials with water-triggered drug-release properties for localized therapeutics

The Board of Regents of the University of Texas System · Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9986723

Screen and use of therapeutics for pancreatic ductal adenocarcinoma

The Board of Regents of the University of Texas System · Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9980956

Methods and therapeutic combinations for treating tumors

The Board of Regents of the University of Texas System · Granted Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9982265

Inhibition of Bruton's tyrosine kinase (Btk) in the lung to treat severe lung inflammation

The Board of Regents of the University of Texas System · Granted Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9980936

BH4 antagonists and methods related thereto

The Board of Regents of the University of Texas System · Granted Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9974850

Immunogenic compositions and uses thereof

The Board of Regents of the University of Texas System · Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9975959

Administration of kynurenine depleting enzymes for tumor therapy

The Board of Regents of the University of Texas System · Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9977033

Methods for assessing cancer recurrence

The Board of Regents of the University of Texas System · Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9962368

Pro-neurogenic compounds

The Board of Regents of the University of Texas System · Granted Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9956172

Implant compositions for the unidirectional delivery of therapeutic compounds to the brain

The Board of Regents of the University of Texas System · Granted Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9937256

Hydrogels for delivery of therapeutic compounds

The Board of Regents of the University of Texas System · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9937156

Modulation of MRTF-A activity in pathologic fibrosis and wound healing

The Board of Regents of the University of Texas System · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9932564

Recombinant isfahan viral vectors

The Board of Regents of the University of Texas System · Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9926380

Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease

The Board of Regents of the University of Texas System · Granted Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9925180

Compounds and anti-tumor NQO1 substrates

The Board of Regents of the University of Texas System · Granted Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9918968

Rapamycin analogs targeting proteasome function in the treatment of cancer

The Board of Regents of the University of Texas System · Granted Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9918959

TLR-independent small molecule adjuvants

The Board of Regents of the University of Texas System · Granted Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9921223

Analysis of genomic DNA, RNA, and proteins in exosomes for diagnosis and theranosis

The Board of Regents of the University of Texas System · Granted Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9913820

Antimicrobial compositions comprising glyceryl nitrates

The Board of Regents of the University of Texas System · Granted Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9914775

Methods for treating inflammatory disorders or cancer metastasis by administering antibodi

The Board of Regents of the University of Texas System · Granted Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9907820

Polyclonal gamma delta T cells for immunotherapy

The Board of Regents of the University of Texas System · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted